Skip to main content
Pangea Wellness Inc. logo

Pangea Wellness Inc. — Investor Relations & Filings

Ticker · PNGA ISIN · CA6979501039 CSE Manufacturing
Open in API
Filings indexed 168 across all filing types
Latest filing 2026-04-23 Interim / Quarterly Rep…
Country CA Canada
Listing CSE PNGA

About Pangea Wellness Inc.

https://pangea-wellness.com/

Pangea Wellness Inc. is a North American manufacturer and distributor specializing in clean-label foods and innovative wellness products. The company focuses on creating high-quality, plant-based products that emphasize nutrition, sustainability, and convenience. Pangea Wellness operates through multiple brands, including its subsidiary, Amino Innovations, which develops science-backed wellness solutions. Amino Innovations specializes in advanced peptide therapies (such as BPC and Epitalon) delivered via accessible oral and topical systems, aiming to provide effective alternatives to traditional methods. Pangea Wellness products are distributed across North America, available online and in over 500 premium retail locations.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Unaudited Condensed Consolidated Interim Financial Statements' for Namibia Critical Metals Inc. for the three months ended February 28, 2026. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Equity, and Statement of Cash Flows) along with detailed explanatory notes. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2026
2026-04-23 English
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal Notice of Meeting and Record Dates sent to regulators and exchanges regarding the Annual General Meeting of The Precision Peptide Company Inc. It details meeting type, record dates, and voting security details. This is part of the proxy solicitation process (materials sent to shareholders to inform them of the meeting and solicit proxies), rather than an earnings release, management change, or AGM materials. Therefore, it best fits the Proxy Solicitation & Information Statement category (PSI).
2026-04-21 English
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice to security holders of the upcoming Annual General Meeting, including record dates, meeting date, location, and proxy materials arrangements. This constitutes materials sent to shareholders to provide information about the meeting and solicit their votes. Under our taxonomy, that aligns with “Proxy Solicitation & Information Statement (PSI).”
2026-04-21 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release rather than a formal financial report, conference call transcript, or regulatory filing form. It provides commentary on FDA regulatory action and includes a grant of stock options under the company’s incentive plan. It does not announce an earnings release, capital raise, dividend, AGM materials, or management discussion, nor is it an annual or interim report. There is no formal report attached, so it isn’t an RPA or 10-K/IR. As it does not neatly fit any specific category, it defaults to the fallback “Regulatory Filings” category (RNS).
2026-04-16 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a French-language prospectus summary (“sommaire”) and pricing supplement for a new structured notes offering by RBC Global Asset Management. It details the terms of the debt issuance (indexed notes, coupon, maturity, barriers, examples of payoffs) and references the base shelf prospectus and supplements filed with securities regulators. This is clearly an issuance of debt securities (capital raising) rather than an annual report, earnings release, or management presentation. Therefore it should be classified as a Capital/Financing Update (CAP).
2026-04-15 French
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing the entry into public relations and consulting services agreements with Think Ink and Ouimet. It does not present financial results, management appointments, M&A activity, share transactions, or any other highly specific event type. It is not a report publication announcement. Hence, it falls into the general regulatory announcements fallback category (RNS).
2026-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.